Result Summary for 101468/165
| Protocol ID: | 101468/165 |
| Clinical Study ID: | 101468/165 |
| Official Title: | An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 8 mg) compared to the ropinirole CR (4 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. |
| Phase: | Phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | ropinirole |
| Trade/Product Name: | Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
